Safety Assessment of Anhydrogalactose,Anhydroglucitol,Anhydroxylitol,Arabinose,Psicose,Saccharide Hydrolysate,and Saccharide Isomerate as Used in Cosmetics
Restricted accessResearch articleFirst published online December, 2025
Safety Assessment of Anhydrogalactose,Anhydroglucitol,Anhydroxylitol,Arabinose,Psicose,Saccharide Hydrolysate,and Saccharide Isomerate as Used in Cosmetics
The Expert Panel for Cosmetic Ingredient Safety (Panel) reviewed the safety of 7 saccharides/saccharide derivatives as used in cosmetic products; all of these ingredients are reported to function as skin-conditioning agents—humectant in cosmetics. The Panel reviewed data relevant to the safety of these ingredients in cosmetic formulations and concluded that Anhydrogalactose, Anhydroglucitol, Anhydroxylitol, Arabinose, Psicose, Saccharide Hydrolysate, and Saccharide Isomerate are safe in cosmetics in the present practices of use and concentration described in this safety assessment.
FiumeMMBergfeldWFBelsitoDV, et al.Safety assessment of monosaccharides, disaccharides, and related ingredients as used in cosmetics. Int J Technoethics. 2019;38(1):5S-38S.
MoritaMAkanumaH. Distribution of 1,5-anhydro-D-glucitol in normal, diabetic, and perfused rat bodies. J Biochem. 1992;112(3):385-388.
5.
SuzukiMMizunoHAkanumaYAkanumaH. Synthesis of 1,5-anhydro-D-glucitol from glucose in rat hepatoma cells. J Biochem. 1994;115(1):87-92.
6.
HanYKwonEYYuMK, et al.A preliminary study for evaluating the dose-dependent effect of D-allulose for fat mass reduction in adult humans: a randomized, double-blind, placebo-controlled trial. Nutrients. 2018;10(2):160.
7.
KimJHYunEJYuSKimKHKangNJ. Different levels of skin whitening activity among 3,6-anhydro-L-galactose, agarooligosaccharides, and neoagarooligosaccharides. Mar Drugs. 2017;15(10):321.
8.
MuWZhangWFengYJiangBZhouL. Recent advances on applications and biotechnological production of D-psicose. Appl Microbiol Biotechnol. 2012;94(6):1461-1467.
9.
United States Pharmacopeial Convention. Food Chemicals Codex. 10th ed.Rockville, MD: The United States Pharmacopeial Convention; 2016.
Perkin-Elmer Informatics. Chemdraw version 19. 2020.
12.
United States Environmental Protection Agency (USEPA). Estimation Programs InterfaceTM for MicrosoftR Windows, v 4.11. Washington, DC, USA: United States Environmental Protection Agency; 2019.
13.
Anonymous. Summary information on Saccharide Isomerate. Unpublished data submitted by the Personal Care Products Council on 11-30-2020; 2020.
14.
KiaLab. Toxicological information on D-Arabinose. Unpublished data submitted by the Personal Care Products Council on 11-20-2020; 2015.
15.
DSM Nutritional Products, Ltd. CIR call for data for “Safety Assessment of Saccharide Humectants as Used in Cosmetics” - 2020 (November 30, 2020 memo). Unpublished data submitted by the Personal Care Products Council on 11-30-2020; 2020.
16.
PathirajaDLeeSChoiI-G. Model-based complete enzymatic production of 3,6-Anhydro-l-galactose from red algal biomass. J Agric Food Chem. 2018;66:6814-6821.
17.
YunEJLeeSKimJH, et al.Enzymatic production of 3,6-anhydro-L-galactose from agarose and its purification and in vitro skin whitening and anti-inflammatory activities. Appl Microbiol Biotechnol. 2013;97(7):2961-2970.
18.
KimDHYunEJLeeS-HKimKH. Novel two-step process utilizing a single enzyme for the production of high-titer 3,6-Anhydro-l-galactose from agarose derived from red macroalgae. J Agric Food Chem. 2018;66(46):12249-12256.
19.
SEPPIC. SEPPIC position on Anhydroxylitol - CIR report on Saccharide Isomerate. Unpublished data submitted by the Personal Care Products Council on 1-27-2021; 2021.
20.
Anonymous. Method of manufacture: D-Arabinose. Unpublished data submitted by the Personal Care Products Council on 11-20-2020; 2020.
21.
NishiokaKKatayamaISanoS. Urticaria induced by D-psicose. Lancet. 1983;2(8364):1417-1418.
22.
ItohHSatoTIzumoriK. Preparation of D-psicose from D-fructose by immobilized D-tagatose 3-epimerase. J Ferment Bioeng. 1995;80(1):101-103.
23.
U.S. Food and Drug Administration Center for Food Safety & Applied Nutrition (CFSAN). Voluntary cosmetic registration program - Frequency of use of cosmetic ingredients. College Park, MD. 2021. Obtained under the Freedom of Information Act from CFSAN; requested as “Frequency of Use Data” January 4, 2021; received January 21, 2021.
24.
Personal Care Products Council. Concentration of use by FDA product category: saccharide humectants. Unpublished data submitted by the Personal Care Products Council on 1-31-2019; 2019.
25.
RotheHFautzRGerberE, et al.Special aspects of cosmetic spray safety evaluations: principles on inhalation risk assessment. Toxicol Lett. 2011;205(2):97-104.
26.
BremmerHJPrud’homme de LodderLCHEngelenJGM. Cosmetics Fact Sheet: To Assess the Risks for the Consumer; Updated Version for ConsExpo 4. Bilthoven, Netherlands: RIVM 320104001/2006; 2006:1-77. https://www.rivm.nl/bibliotheek/rapporten/320104001.pdf. Accessed August 24, 2011.
27.
RotheH. Special aspects of cosmetic spray evaluation. Unpublished information presented to the 26 September CIR Expert Panel. Washington D.C; 2011.
28.
JohnsenMA. The influence of particle size. Spray Technol Market. 2004;14(11):24-27.
XuJWhongWZOngT. Validation of the Salmonella (SV50)/arabinose-resistant forward mutation assay system with 26 compounds. Mutat Res. 1984;130(2):79-86.
32.
WrightTEMartinDQuallsCCuretLB. Effects of intrapartum administration of invert sugar and D5LR on neonatal blood glucose levels. J Perinatol. 2000;20(4):217-218.
33.
RosenbergerV. Urban skin hydration is a global challenge. Happi. New York: Rodman Media; 2018:74-76.
34.
PitkänenEPitkänenO. The elimination of 1,5-anhydroglucitol administered to rats. Experientia. 1984;40(5):463-465.
35.
WhistlerRLSinghPPLakeWC. D-Psicose metabolism in the rat. Carbohydr Res. 1974;34(1):200-202.
36.
TsukamotoIHossainAYamaguchiF, et al.Intestinal absorption, organ distribution, and urinary excretion of the rare sugar D-psicose. Drug Des Devel Ther. 2014;8:1955-1964.
37.
YamanouchiTTachibanaYAkanumaH, et al.Origin and disposal of 1,5-anhydroglucitol, a major polyol in the human body. Am J Physiol. 1992;263(2 Pt 1):E268-E273.
38.
McIntoshJC. The excretion of sugars in human urine. Clin Chim Acta. 1984;143(2):169-172.
39.
LobleyRWBurrowsPCWarwickRDawsonDJHolmesR. Simultaneous assessment of intestinal permeability and lactose tolerance with orally administered raffinose, lactose and L-arabinose. Clin Sci (Lond). 1990;79(2):175-183.
40.
HigakiSMatsuoT. Toxicity of d-arabinose in male and female rats (Abstract). Shokuhin Eiseigaku Zasshi. 2018;59(3):114-120.
41.
MatsuoTTanakaTHashiguchiMIzumoriKSuzukiH. Effects of oral acute administration and subchronic feeding of several levels of D-psicose in rats. J Nutr Sci Vitaminol (Tokyo). 2002;48(6):512-516.
42.
NishiiNNomizoTTakashimaSMatsubaraTTokudaMKitagawaH. Single oral dose safety of D-allulose in dogs. J Vet Med Sci. 2016;78(6):1079-1083.
43.
SunaSYamaguchiFKimuraSTokudaMJitsunariF. Preventive effect of D-psicose, one of rare ketohexoses, on di-(2-ethylhexyl) phthalate (DEHP)-induced testicular injury in rat. Toxicol Lett. 2007;173(2):107-117.
44.
NishiiNTakashimaSKobatakeYTokudaMKitagawaH. The long-term safety of D-allulose administration in healthy dogs. J Vet Med Sci. 2017;79(11):1780-1784.
45.
YagiKMatsuoT. The study on long-term toxicity of d-psicose in rats. J Clin Biochem Nutr. 2009;45(3):271-277.
46.
HueperWC. Are sugars carcinogens? An experimental study. Cancer Res. 1965;25:440-443.
47.
SuiLDongYWatanabeY, et al.The inhibitory effect and possible mechanisms of D-allose on cancer cell proliferation. Int J Oncol. 2005;27(4):907-912.
48.
YunEJLeeARKimJHChoKMKimKH. 3,6-Anhydro-L-galactose, a rare sugar from agar, a new anticariogenic sugar to replace xylitol. Food Chem. 2017;221:976-983.
49.
DendaM. Effects of topical application of aqueous solutions of hexoses on epidermal permeability barrier recovery rate after barrier disruption. Exp Dermatol. 2011;20(11):943-944.
50.
Clinical Research Laboratories, Inc. Repeated insut patch trest (Marzulli and Maibach method) of an eye cream containing 2.75% saccharide isomerate. Unpublished data submitted by the Personal Care Products Council on February 10, 2020; 2011.
51.
Clinical Research Laboratories, Inc. An evaluation of the ophthalmic safety and efficacy of an eye cream containing 2.75% saccharide isomerate. Unpublished data submitted by the Personal Care Products Council on February 10, 2020; 2011.
52.
OnkenhoutWGroenerJEVerhoevenNMYinCLaanLA. L-Arabinosuria: a new defect in human pentose metabolism. Mol Genet Metab. 2002;77(1-2):80-85.
53.
NishiokaKKatayamaISanoSNumataTYamamotoS. Monosaccharide in high fructose syrup as an etiological factor of urticaria. J Dermatol. 1984;11(4):391-396.
54.
HayashiNIidaTYamadaT, et al.Study on the postprandial blood glucose suppression effect of D-psicose in borderline diabetes and the safety of long-term ingestion by normal human subjects. Biosci Biotechnol Biochem. 2010;74(3):510-519.
